May 13, 2025 9:31 am
Trump said he would introduce a “most favoured nation” (MFN) policy whereby the US pays “the same price as the nation that pays the lowest price anywhere in the World".
January 27, 2025 7:01 pm
According to the ED, the total attachment and seizure in the money laundering case against Sharon Bio-Medicine has now reached Rs 96.20 crore.
September 11, 2023 2:12 pm
A study of 186 drug makers, which accounted for about half of the Rs 3.7 lakh crore annual revenue of the sector last fiscal, indicates as much, Crisil said on Monday.
June 28, 2023 8:59 am
The company, Marion Biotech, bought the ingredient — propylene glycol (PG) — from trader Maya Chemtech India, as reported by Reuters. But Maya did not have a licence to sell pharmaceutical-grade materials and "dealt in industrial-grade only."
June 22, 2018 12:16 am
Numerous cases of data falsification, lax adherence to norms, says report
August 29, 2017 2:56 am
After years of constant denial, it appears that in the draft policy, the government is finally ready to accept that there is a problem with the drugs that are manufactured and sold in India. The Draft Pharmaceutical Policy 2017, prepared by the Department of Pharmaceuticals, has an entire paragraph dedicated to the quality concerns that affect the domestic market.
August 29, 2017 2:55 am
While Sun Pharma and Glenmark Pharma submitted detailed responses that includes revising standard operating procedures and re-training employees to the USFDA to deal with its adverse observations, others have begun course-correction
February 22, 2014 11:39 am
While allaying apprehensions that the US is not targeting Indian companies, they said its a routine inspection followed across countries.
February 02, 2014 10:37 am
Before Toansa, its three other plants in India had already been blacklisted by the FDA. (Photo: Reuters)
January 09, 2014 4:56 pm
DIPP had proposed a slew of measures to revamp FDI policy for the sector.


